Quest Partners LLC Delcath Systems, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1,762 shares of DCTH stock, worth $17,637. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,762
Previous 1
176100.0%
Holding current value
$17,637
Previous $13,000
184230.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DCTH
# of Institutions
117Shares Held
13.1MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.61MShares$16.1 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.14 Million0.26% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$7.51 Million2.59% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.04 Million0.0% of portfolio
-
Exodus Point Capital Management, LP New York, NY699KShares$7 Million0.09% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $86.1M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...